Therapeutic exploitation of the p53 pathway

作者: David P. Lane , Sonia Lain

DOI: 10.1016/S1471-4914(02)02309-2

关键词:

摘要: Analysis of the gene encoding p53 could serve to evaluate effectiveness a cancer treatment. Mutations in this occur half all human cancers, and regulation protein is defective variety others. Novel strategies that exploit our knowledge function are being actively investigated. Strategies directed at treating tumours have mutations include therapy, viruses only replicate deficient cells, search for small molecules reactivate mutant p53. Potentiating non-genotoxic way express wildtype can be achieved by inhibiting expression Mdm2 or viral oncoproteins.

参考文章(33)
Chène P, Howard Sf, Lane Dp, Picksley Sm, Böttger, Hochkeppel Hk, Garcia-Echeverria C, Böttger A, Identification of novel mdm2 binding peptides by phage display. Oncogene. ,vol. 13, pp. 2141- 2147 ,(1996)
Shie-Pon Tzung, Kristine M. Kim, Gorka Basañez, Chris D. Giedt, Julian Simon, Joshua Zimmerberg, Kam Y. J. Zhang, David M. Hockenbery, Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3. Nature Cell Biology. ,vol. 3, pp. 183- 191 ,(2001) , 10.1038/35055095
Jason D. Weber, Laura J. Taylor, Martine F. Roussel, Charles J. Sherr, Dafna Bar-Sagi, Nucleolar Arf sequesters Mdm2 and activates p53 Nature Cell Biology. ,vol. 1, pp. 20- 26 ,(1999) , 10.1038/8991
Sudhir Agrawal, Ruiwen Zhang, Li Nan, Hui Wang, Dong Yu, Antisense Anti-MDM2 Oligonucleotides As a Novel Therapeutic Approach to Human Breast Cancer In Vitro and in Vivo Activities and Mechanisms Clinical Cancer Research. ,vol. 7, pp. 3613- 3624 ,(2001)
Monica Hollstein, Manfred Hergenhahn, Qin Yang, Helmut Bartsch, Zhao-Qi Wang, Pierre Hainaut, New approaches to understanding p53 gene tumor mutation spectra Mutation Research. ,vol. 431, pp. 199- 209 ,(1999) , 10.1016/S0027-5107(99)00162-1
Miranda Thomas, David Pim, Lawrence Banks, The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene. ,vol. 18, pp. 7690- 7700 ,(1999) , 10.1038/SJ.ONC.1202953
Lawrence A. Donehower, The p53-deficient mouse: a model for basic and applied cancer studies. Seminars in Cancer Biology. ,vol. 7, pp. 269- 278 ,(1996) , 10.1006/SCBI.1996.0035
S. Hietanen, S. Lain, E. Krausz, C. Blattner, D. P. Lane, Activation of p53 in cervical carcinoma cells by small molecules. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 97, pp. 8501- 8506 ,(2000) , 10.1073/PNAS.97.15.8501
Wei-Li Liu, Carol Midgley, Charles Stephen, Mark Saville, David P Lane, Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein. Journal of Molecular Biology. ,vol. 313, pp. 711- 731 ,(2001) , 10.1006/JMBI.2001.5082
Sonia Laı́n, Dimitris Xirodimas, David P. Lane, Accumulating active p53 in the nucleus by inhibition of nuclear export: a novel strategy to promote the p53 tumor suppressor function. Experimental Cell Research. ,vol. 253, pp. 315- 324 ,(1999) , 10.1006/EXCR.1999.4672